Literature DB >> 16929910

[Cyclosporine A effect in mice C57BL/6 infected with Encephalitozoon intestinalis].

Ana Luz Galván1, Sonia del Pilar Agudelo, Juan Gonzalo Restrepo, Fabiola Toro, Luisa Alejandra Galviz, Jorge Botero.   

Abstract

INTRODUCTION: Encephalitozoon intestinalis, a parasite belonging to the phylum Microsporidia, is causes gastrointestinal infections in the immunocompromised host. A suitable pharmacologically immunosuppressed animal model for the study of natural E. intestinalis infection, which can establish the immune components that respond to this parasite, is lacking.
OBJECTIVE: To evaluate the effect of immunosuuppression with Cyclosporine A (CsA) in C57BL/ 6 mice on experimental infection with E. intestinalis infection.
MATERIALS AND METHODS: Eighty C57BL/6 mice were distributed in four treatment groups: Control, CsA-immunosuppressed mice without infection, immunocompetent and immunossuppressed mice infected with E. intestinalis. Mice were immunosuppressed with a weekly dose of 50 mg/Kg body weight of CsA, during the course of the study. Five mice from each group were sacrificed 2, 3, 4 and 6 weeks post-infection, to obtain blood for antibody testing and stool samples were analyzed to assess excretion of spores.
RESULTS: Production of specific IgG antibodies was significantly higher in the immunocompetent group as compared to the immunosuppressed group of experimentally infected mice. In the infected mice, parasites were not observed in any tissues different from the small intestine. However, spore excretion through the stool and duodenal liquid was higher in the group of immunosuppresed infected mice.
CONCLUSION: Immunosuppression induced with CsA in the murine model did not allow parasite dissemination and illness progression, but raised kinetics of spore excretion and decreased the production of IgG antibodies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16929910

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  3 in total

1.  Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?

Authors:  Nadia Emi Aikawa; Aline de Oliveira Twardowsky; Jozélio Freire de Carvalho; Clovis A Silva; Ivan Leonardo Avelino França E Silva; Ana Cristina de Medeiros Ribeiro; Carla Goncalves Schain Saad; Julio César Bertacini Moraes; Roberto Acayaba de Toledo; Eloísa Bonfá
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

2.  Bilateral microsporidial keratoconjunctivitis in a clinically healthy female receiving intravitreal steroid injections: Associations and potential risk factors.

Authors:  Timothy Y Chou; Jahnvi Bansal; Roberta Seidman; Afra Rahman; Delia Montalto
Journal:  Am J Ophthalmol Case Rep       Date:  2022-07-09

3.  Development of a three-dimensional tissue construct from dental human ectomesenchymal stem cells: in vitro and in vivo study.

Authors:  Daniela Guzmán-Uribe; Keila Neri Alvarado Estrada; Amaury de Jesús Pozos Guillén; Silvia Martín Pérez; Raúl Rosales Ibáñez
Journal:  Open Dent J       Date:  2012-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.